Atlas Trials

Effectiveness of Aprepitant in Addition to Ondansetron in the Prevention of Nausea and Vomiting Caused by Upper Abdominal Radiotherapy

Clinical trial NCT00970905 · COMPLETED

Trial details

NCT number
NCT00970905
Sponsor
University of Vermont
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
NauseaVomiting
Start date
2009-10-01
Primary completion
2016-07-01
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.